Rep. Brady Issues Statement on CBO Analysis on Drug Pricing Legislation
October 11, 2019
October 11, 2019
WASHINGTON, Oct. 11 -- Rep. Kevin Brady, R-Texas, ranking Republican member of the House Ways and Means Committee, issued the following statement after the Congressional Budget Office published an analysis on drug pricing legislation (H.R. 3) by House Speaker Nancy Pelosi, D-California:
"CBO's report confirms House Democrats' 'dictate or destroy' price controls only serve to hurt the development of future cures and damage American innovation.
"To protect the h . . .
"CBO's report confirms House Democrats' 'dictate or destroy' price controls only serve to hurt the development of future cures and damage American innovation.
"To protect the h . . .